Human Organs-on-Chips Market Insights, Global Outlook and Forecast 2022-2028
An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney).
In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
The latest research study released by Market IntelliX evaluates market size and forecasts of Human Organs-on-Chips in global, including the following market information:
Global Human Organs-on-Chips Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Human Organs-on-Chips Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Human Organs-on-Chips companies in 2021 (%)
The global Human Organs-on-Chips market was valued at 69 million in 2021 and is projected to reach US$ 154.4 million by 2028, at a CAGR of 12.2% during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Brain-on-a-chip Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Human Organs-on-Chips include Emulate, TissUse, Hesperos, CN Bio Innovations, Tara Biosystems, Draper Laboratory, Mimetas, Nortis and Micronit Microtechnologies B.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MI has surveyed the Human Organs-on-Chips manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Market Segmentations:
Global Human Organs-on-Chips Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Organs-on-Chips Market Segment Percentages, by Type, 2021 (%)
Brain-on-a-chip
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Vessel-on-a-chip
Other Organs
Global Human Organs-on-Chips Market, by End User, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Organs-on-Chips Market Segment Percentages, by End User, 2021 (%)
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Others
Global Human Organs-on-Chips Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Human Organs-on-Chips Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Organs-on-Chips revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Human Organs-on-Chips revenues share in global market, 2021 (%)
Key companies Human Organs-on-Chips sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Human Organs-on-Chips sales share in global market, 2021 (%)
The report presents profiles of competitors in the market Some of the prominent key players covered:
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Key Takeaways from this Report
Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level – for product types, end use applications and by different industry verticals.
Understand the different dynamics influencing the market – key driving factors, challenges and hidden opportunities.
Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
Analyze the sales and distribution channels across key geographies to improve top-line revenues.
Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
Get a quick outlook on the market entropy – M&A’s, deals, partnerships, product launches of all key players for the past 4 years.
Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
1 Introduction to Research & Analysis Reports
1.1 Human Organs-on-Chips Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End User
1.3 Global Human Organs-on-Chips Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Organs-on-Chips Overall Market Size
2.1 Global Human Organs-on-Chips Market Size: 2021 VS 2028
2.2 Global Human Organs-on-Chips Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Human Organs-on-Chips Sales: 2017-2028
3 Company Landscape
3.1 Top Human Organs-on-Chips Players in Global Market
3.2 Top Global Human Organs-on-Chips Companies Ranked by Revenue
3.3 Global Human Organs-on-Chips Revenue by Companies
3.4 Global Human Organs-on-Chips Sales by Companies
3.5 Global Human Organs-on-Chips Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Human Organs-on-Chips Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Human Organs-on-Chips Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Organs-on-Chips Players in Global Market
3.8.1 List of Global Tier 1 Human Organs-on-Chips Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Organs-on-Chips Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Organs-on-Chips Market Size Markets, 2021 & 2028
4.1.2 Brain-on-a-chip
4.1.3 Liver-on-a-chip
4.1.4 Kidney-on-a-chip
4.1.5 Lung-on-a-chip
4.1.6 Heart-on-a-chip
4.1.7 Intestine-on-a-chip
4.1.8 Vessel-on-a-chip
4.1.9 Other Organs
4.2 By Type - Global Human Organs-on-Chips Revenue & Forecasts
4.2.1 By Type - Global Human Organs-on-Chips Revenue, 2017-2022
4.2.2 By Type - Global Human Organs-on-Chips Revenue, 2023-2028
4.2.3 By Type - Global Human Organs-on-Chips Revenue Market Share, 2017-2028
4.3 By Type - Global Human Organs-on-Chips Sales & Forecasts
4.3.1 By Type - Global Human Organs-on-Chips Sales, 2017-2022
4.3.2 By Type - Global Human Organs-on-Chips Sales, 2023-2028
4.3.3 By Type - Global Human Organs-on-Chips Sales Market Share, 2017-2028
4.4 By Type - Global Human Organs-on-Chips Price (Manufacturers Selling Prices), 2017-2028
5 Sights By End User
5.1 Overview
5.1.1 By End User - Global Human Organs-on-Chips Market Size, 2021 & 2028
5.1.2 Pharmaceutical & Biotechnology Companies
5.1.3 Academic & Research Institutes
5.1.4 Cosmetics Industry
5.1.5 Others
5.2 By End User - Global Human Organs-on-Chips Revenue & Forecasts
5.2.1 By End User - Global Human Organs-on-Chips Revenue, 2017-2022
5.2.2 By End User - Global Human Organs-on-Chips Revenue, 2023-2028
5.2.3 By End User - Global Human Organs-on-Chips Revenue Market Share, 2017-2028
5.3 By End User - Global Human Organs-on-Chips Sales & Forecasts
5.3.1 By End User - Global Human Organs-on-Chips Sales, 2017-2022
5.3.2 By End User - Global Human Organs-on-Chips Sales, 2023-2028
5.3.3 By End User - Global Human Organs-on-Chips Sales Market Share, 2017-2028
5.4 By End User - Global Human Organs-on-Chips Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Human Organs-on-Chips Market Size, 2021 & 2028
6.2 By Region - Global Human Organs-on-Chips Revenue & Forecasts
6.2.1 By Region - Global Human Organs-on-Chips Revenue, 2017-2022
6.2.2 By Region - Global Human Organs-on-Chips Revenue, 2023-2028
6.2.3 By Region - Global Human Organs-on-Chips Revenue Market Share, 2017-2028
6.3 By Region - Global Human Organs-on-Chips Sales & Forecasts
6.3.1 By Region - Global Human Organs-on-Chips Sales, 2017-2022
6.3.2 By Region - Global Human Organs-on-Chips Sales, 2023-2028
6.3.3 By Region - Global Human Organs-on-Chips Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Human Organs-on-Chips Revenue, 2017-2028
6.4.2 By Country - North America Human Organs-on-Chips Sales, 2017-2028
6.4.3 US Human Organs-on-Chips Market Size, 2017-2028
6.4.4 Canada Human Organs-on-Chips Market Size, 2017-2028
6.4.5 Mexico Human Organs-on-Chips Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Human Organs-on-Chips Revenue, 2017-2028
6.5.2 By Country - Europe Human Organs-on-Chips Sales, 2017-2028
6.5.3 Germany Human Organs-on-Chips Market Size, 2017-2028
6.5.4 France Human Organs-on-Chips Market Size, 2017-2028
6.5.5 U.K. Human Organs-on-Chips Market Size, 2017-2028
6.5.6 Italy Human Organs-on-Chips Market Size, 2017-2028
6.5.7 Russia Human Organs-on-Chips Market Size, 2017-2028
6.5.8 Nordic Countries Human Organs-on-Chips Market Size, 2017-2028
6.5.9 Benelux Human Organs-on-Chips Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Human Organs-on-Chips Revenue, 2017-2028
6.6.2 By Region - Asia Human Organs-on-Chips Sales, 2017-2028
6.6.3 China Human Organs-on-Chips Market Size, 2017-2028
6.6.4 Japan Human Organs-on-Chips Market Size, 2017-2028
6.6.5 South Korea Human Organs-on-Chips Market Size, 2017-2028
6.6.6 Southeast Asia Human Organs-on-Chips Market Size, 2017-2028
6.6.7 India Human Organs-on-Chips Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Human Organs-on-Chips Revenue, 2017-2028
6.7.2 By Country - South America Human Organs-on-Chips Sales, 2017-2028
6.7.3 Brazil Human Organs-on-Chips Market Size, 2017-2028
6.7.4 Argentina Human Organs-on-Chips Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Organs-on-Chips Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Human Organs-on-Chips Sales, 2017-2028
6.8.3 Turkey Human Organs-on-Chips Market Size, 2017-2028
6.8.4 Israel Human Organs-on-Chips Market Size, 2017-2028
6.8.5 Saudi Arabia Human Organs-on-Chips Market Size, 2017-2028
6.8.6 UAE Human Organs-on-Chips Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Emulate
7.1.1 Emulate Corporate Summary
7.1.2 Emulate Business Overview
7.1.3 Emulate Human Organs-on-Chips Major Product Offerings
7.1.4 Emulate Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.1.5 Emulate Key News
7.2 TissUse
7.2.1 TissUse Corporate Summary
7.2.2 TissUse Business Overview
7.2.3 TissUse Human Organs-on-Chips Major Product Offerings
7.2.4 TissUse Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.2.5 TissUse Key News
7.3 Hesperos
7.3.1 Hesperos Corporate Summary
7.3.2 Hesperos Business Overview
7.3.3 Hesperos Human Organs-on-Chips Major Product Offerings
7.3.4 Hesperos Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.3.5 Hesperos Key News
7.4 CN Bio Innovations
7.4.1 CN Bio Innovations Corporate Summary
7.4.2 CN Bio Innovations Business Overview
7.4.3 CN Bio Innovations Human Organs-on-Chips Major Product Offerings
7.4.4 CN Bio Innovations Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.4.5 CN Bio Innovations Key News
7.5 Tara Biosystems
7.5.1 Tara Biosystems Corporate Summary
7.5.2 Tara Biosystems Business Overview
7.5.3 Tara Biosystems Human Organs-on-Chips Major Product Offerings
7.5.4 Tara Biosystems Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.5.5 Tara Biosystems Key News
7.6 Draper Laboratory
7.6.1 Draper Laboratory Corporate Summary
7.6.2 Draper Laboratory Business Overview
7.6.3 Draper Laboratory Human Organs-on-Chips Major Product Offerings
7.6.4 Draper Laboratory Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.6.5 Draper Laboratory Key News
7.7 Mimetas
7.7.1 Mimetas Corporate Summary
7.7.2 Mimetas Business Overview
7.7.3 Mimetas Human Organs-on-Chips Major Product Offerings
7.7.4 Mimetas Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.7.5 Mimetas Key News
7.8 Nortis
7.8.1 Nortis Corporate Summary
7.8.2 Nortis Business Overview
7.8.3 Nortis Human Organs-on-Chips Major Product Offerings
7.8.4 Nortis Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.8.5 Nortis Key News
7.9 Micronit Microtechnologies B.V.
7.9.1 Micronit Microtechnologies B.V. Corporate Summary
7.9.2 Micronit Microtechnologies B.V. Business Overview
7.9.3 Micronit Microtechnologies B.V. Human Organs-on-Chips Major Product Offerings
7.9.4 Micronit Microtechnologies B.V. Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.9.5 Micronit Microtechnologies B.V. Key News
7.10 Kirkstall
7.10.1 Kirkstall Corporate Summary
7.10.2 Kirkstall Business Overview
7.10.3 Kirkstall Human Organs-on-Chips Major Product Offerings
7.10.4 Kirkstall Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.10.5 Kirkstall Key News
7.11 Cherry Biotech SAS
7.11.1 Cherry Biotech SAS Corporate Summary
7.11.2 Cherry Biotech SAS Human Organs-on-Chips Business Overview
7.11.3 Cherry Biotech SAS Human Organs-on-Chips Major Product Offerings
7.11.4 Cherry Biotech SAS Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.11.5 Cherry Biotech SAS Key News
7.12 Else Kooi Laboratory
7.12.1 Else Kooi Laboratory Corporate Summary
7.12.2 Else Kooi Laboratory Human Organs-on-Chips Business Overview
7.12.3 Else Kooi Laboratory Human Organs-on-Chips Major Product Offerings
7.12.4 Else Kooi Laboratory Human Organs-on-Chips Sales and Revenue in Global (2017-2022)
7.12.5 Else Kooi Laboratory Key News
8 Global Human Organs-on-Chips Production Capacity, Analysis
8.1 Global Human Organs-on-Chips Production Capacity, 2017-2028
8.2 Human Organs-on-Chips Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Organs-on-Chips Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Organs-on-Chips Supply Chain Analysis
10.1 Human Organs-on-Chips Industry Value Chain
10.2 Human Organs-on-Chips Upstream Market
10.3 Human Organs-on-Chips Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Organs-on-Chips Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Human Organs-on-Chips in Global Market
Table 2. Top Human Organs-on-Chips Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Human Organs-on-Chips Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Human Organs-on-Chips Revenue Share by Companies, 2017-2022
Table 5. Global Human Organs-on-Chips Sales by Companies, (K Units), 2017-2022
Table 6. Global Human Organs-on-Chips Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Human Organs-on-Chips Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Human Organs-on-Chips Product Type
Table 9. List of Global Tier 1 Human Organs-on-Chips Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Organs-on-Chips Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Human Organs-on-Chips Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Human Organs-on-Chips Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Human Organs-on-Chips Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Human Organs-on-Chips Sales (K Units), 2017-2022
Table 15. By Type - Global Human Organs-on-Chips Sales (K Units), 2023-2028
Table 16. By End User – Global Human Organs-on-Chips Revenue, (US$, Mn), 2021 & 2028
Table 17. By End User - Global Human Organs-on-Chips Revenue (US$, Mn), 2017-2022
Table 18. By End User - Global Human Organs-on-Chips Revenue (US$, Mn), 2023-2028
Table 19. By End User - Global Human Organs-on-Chips Sales (K Units), 2017-2022
Table 20. By End User - Global Human Organs-on-Chips Sales (K Units), 2023-2028
Table 21. By Region – Global Human Organs-on-Chips Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Human Organs-on-Chips Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Human Organs-on-Chips Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Human Organs-on-Chips Sales (K Units), 2017-2022
Table 25. By Region - Global Human Organs-on-Chips Sales (K Units), 2023-2028
Table 26. By Country - North America Human Organs-on-Chips Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Human Organs-on-Chips Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Human Organs-on-Chips Sales, (K Units), 2017-2022
Table 29. By Country - North America Human Organs-on-Chips Sales, (K Units), 2023-2028
Table 30. By Country - Europe Human Organs-on-Chips Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Human Organs-on-Chips Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Human Organs-on-Chips Sales, (K Units), 2017-2022
Table 33. By Country - Europe Human Organs-on-Chips Sales, (K Units), 2023-2028
Table 34. By Region - Asia Human Organs-on-Chips Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Human Organs-on-Chips Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Human Organs-on-Chips Sales, (K Units), 2017-2022
Table 37. By Region - Asia Human Organs-on-Chips Sales, (K Units), 2023-2028
Table 38. By Country - South America Human Organs-on-Chips Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Human Organs-on-Chips Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Human Organs-on-Chips Sales, (K Units), 2017-2022
Table 41. By Country - South America Human Organs-on-Chips Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Human Organs-on-Chips Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Human Organs-on-Chips Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Human Organs-on-Chips Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Human Organs-on-Chips Sales, (K Units), 2023-2028
Table 46. Emulate Corporate Summary
Table 47. Emulate Human Organs-on-Chips Product Offerings
Table 48. Emulate Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. TissUse Corporate Summary
Table 50. TissUse Human Organs-on-Chips Product Offerings
Table 51. TissUse Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Hesperos Corporate Summary
Table 53. Hesperos Human Organs-on-Chips Product Offerings
Table 54. Hesperos Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. CN Bio Innovations Corporate Summary
Table 56. CN Bio Innovations Human Organs-on-Chips Product Offerings
Table 57. CN Bio Innovations Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Tara Biosystems Corporate Summary
Table 59. Tara Biosystems Human Organs-on-Chips Product Offerings
Table 60. Tara Biosystems Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Draper Laboratory Corporate Summary
Table 62. Draper Laboratory Human Organs-on-Chips Product Offerings
Table 63. Draper Laboratory Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Mimetas Corporate Summary
Table 65. Mimetas Human Organs-on-Chips Product Offerings
Table 66. Mimetas Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Nortis Corporate Summary
Table 68. Nortis Human Organs-on-Chips Product Offerings
Table 69. Nortis Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Micronit Microtechnologies B.V. Corporate Summary
Table 71. Micronit Microtechnologies B.V. Human Organs-on-Chips Product Offerings
Table 72. Micronit Microtechnologies B.V. Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Kirkstall Corporate Summary
Table 74. Kirkstall Human Organs-on-Chips Product Offerings
Table 75. Kirkstall Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Cherry Biotech SAS Corporate Summary
Table 77. Cherry Biotech SAS Human Organs-on-Chips Product Offerings
Table 78. Cherry Biotech SAS Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Else Kooi Laboratory Corporate Summary
Table 80. Else Kooi Laboratory Human Organs-on-Chips Product Offerings
Table 81. Else Kooi Laboratory Human Organs-on-Chips Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Human Organs-on-Chips Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Human Organs-on-Chips Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Human Organs-on-Chips Production by Region, 2017-2022 (K Units)
Table 85. Global Human Organs-on-Chips Production by Region, 2023-2028 (K Units)
Table 86. Human Organs-on-Chips Market Opportunities & Trends in Global Market
Table 87. Human Organs-on-Chips Market Drivers in Global Market
Table 88. Human Organs-on-Chips Market Restraints in Global Market
Table 89. Human Organs-on-Chips Raw Materials
Table 90. Human Organs-on-Chips Raw Materials Suppliers in Global Market
Table 91. Typical Human Organs-on-Chips Downstream
Table 92. Human Organs-on-Chips Downstream Clients in Global Market
Table 93. Human Organs-on-Chips Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Organs-on-Chips Segment by Type
Figure 2. Human Organs-on-Chips Segment by End User
Figure 3. Global Human Organs-on-Chips Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Human Organs-on-Chips Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Human Organs-on-Chips Revenue, 2017-2028 (US$, Mn)
Figure 7. Human Organs-on-Chips Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Human Organs-on-Chips Revenue in 2021
Figure 9. By Type - Global Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 10. By Type - Global Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 11. By Type - Global Human Organs-on-Chips Price (US$/Unit), 2017-2028
Figure 12. By End User - Global Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 13. By End User - Global Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 14. By End User - Global Human Organs-on-Chips Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 16. By Region - Global Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 17. By Country - North America Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 18. By Country - North America Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 19. US Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 24. Germany Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 25. France Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 33. China Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 37. India Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 39. By Country - South America Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 40. Brazil Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Human Organs-on-Chips Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Human Organs-on-Chips Sales Market Share, 2017-2028
Figure 44. Turkey Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Human Organs-on-Chips Revenue, (US$, Mn), 2017-2028
Figure 48. Global Human Organs-on-Chips Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Human Organs-on-Chips by Region, 2021 VS 2028
Figure 50. Human Organs-on-Chips Industry Value Chain
Figure 51. Marketing Channels
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|